Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,727.44
+14.660.86%
Number of Gainers:5
Number of Losers:2
Number of Flat:- -
PE:- -
High:1,745.93
Open:1,710.27
Low:1,697.28
Close:1,712.79
Volume:60.92M
Turnover:5.75B
Market Cap:1.80T
Float Cap:1.73T

Loading ...

Berenberg Downgrades Novo Nordisk to Hold From Buy, Adjusts Price Target to $47 From $50

MT Newswires Live
·
Aug 12

Press Release: Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results

Dow Jones
·
Aug 12

Eli Lilly Files Six Lawsuits Targeting Black-Market Retatrutide Sellers in US

Reuters
·
Aug 12

Lilly Calls on Online Platforms, Payment Companies and Regulators to Shut Down the Illegal Retatrutide Black Market

THOMSON REUTERS
·
Aug 12

Eli Lilly: Calling on Entities That Sellers Use to Conduct Their Illegal Business-Social Media and E-Commerce Platforms

THOMSON REUTERS
·
Aug 12

Eli Lilly - Reports over 14,000 Unlawful Retatrutide Listings in 100 Countries

THOMSON REUTERS
·
Aug 12

Daiwa Securities Adjusts Price Target on Pfizer to $27 From $28, Maintains Neutral Rating

MT Newswires Live
·
Aug 12

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 12

Amgen to Open New Science & Innovation Center in Genome Valley, Hyderabad

THOMSON REUTERS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Pfizer (PFE) and Sana Biotechnology (SANA)

TIPRANKS
·
Aug 12

Novo Nordisk : Berenberg Cuts to Hold from Buy

THOMSON REUTERS
·
Aug 12

NYSE Most Active Issues

Dow Jones
·
Aug 12

Eli Lilly SVP Finance & CAO Donald A. Zakrowski Lepas 2.000 Saham Senilai USD 2,37 Juta

Reuters
·
Aug 12

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Cboe data shows mixed options sentiment in Pfizer with shares down 1.65%

TIPRANKS
·
Aug 12

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

Novo Nordisk’s New Obesity Metabolism Trial: What Investors Should Watch

TIPRANKS
·
Aug 12

Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors

TIPRANKS
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11